The relationship between the development of erythroderma in patients with atopic dermatitis and the avoidance of anti-inflammatory topical drugs

Allergol Int. 2021 Jul;70(3):376-378. doi: 10.1016/j.alit.2020.11.009. Epub 2020 Dec 24.

Authors

Risa Otsuka¹, Akio Tanaka², Masakazu Takahashi³, Ryo Saito¹, Kazumasa Iwamoto¹, Shunsuke Takahagi¹, Takanobu Kan¹, Satoshi Morioke¹, Michihiro Hide¹

Affiliations

¹ Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
² Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. Electronic address: tantanakiotan@yahoo.co.jp.
³ Graduate School of Innovation and Technology Management, Yamaguchi University, Yamaguchi, Japan.

PMID: 33357979
DOI: 10.1016/j.alit.2020.11.009

No abstract available

Publication types

Letter

MeSH terms

Administration, Topical
Anti-Inflammatory Agents / administration & dosage
Anti-Inflammatory Agents / adverse effects*
Dermatitis, Atopic / complications*
Dermatitis, Atopic / drug therapy
Dermatitis, Exfoliative / etiology*
Disease Susceptibility*
Humans

Substances

Anti-Inflammatory Agents